{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:15:08Z","timestamp":1781129708956,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaad.2025.01.081","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T11:48:25Z","timestamp":1738583305000},"page":"165-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Review of category A bioweapons with cutaneous features: Epidemiology, clinical presentation, and contemporary management strategies"],"prefix":"10.1016","volume":"93","author":[{"given":"Sara","family":"Osborne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Wescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolynne","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashin J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan W.","family":"Rojek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.01.081_bib5","series-title":"StatPearls [Internet]","article-title":"Comprehensive review of bioterrorism","author":"Rathish","year":"2024"},{"issue":"10","key":"10.1016\/j.jaad.2025.01.081_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib7","first-page":"1","article-title":"Anthrax - biological threat in the 21st century","volume":"9","author":"Johari","year":"2002","journal-title":"Malays J Med Sci"},{"key":"10.1016\/j.jaad.2025.01.081_bib8","series-title":"Bioterrorism and infectious agents: a new dilemma for the 21st century","first-page":"37","article-title":"Plague as a biological weapon","author":"Dennis","year":"2009"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.081_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ccc.2013.03.015","article-title":"Biowarfare and bioterrorism","volume":"29","author":"Christian","year":"2013","journal-title":"Crit Care Clin"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.081_bib10","first-page":"195","article-title":"A survey of dermatologists' preparedness for natural and manmade disasters","volume":"19","author":"Murphy","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2025.01.081_bib13","series-title":"Control of Communicable Diseases Manual","year":"2006"},{"issue":"6","key":"10.1016\/j.jaad.2025.01.081_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/clinids\/19.6.1009","article-title":"Anthrax","volume":"19","author":"LaForce","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jaad.2025.01.081_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jaad.2025.01.081_bib16","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMra012892","article-title":"Recognition and management of anthrax--an update","volume":"345","author":"Swartz","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2025.01.081_bib17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s00134-012-2541-0","article-title":"An overview of anthrax infection including the recently identified form of disease in injection drug users","volume":"38","author":"Hicks","year":"2012","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.081_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/ijd.IJD_378_17","article-title":"Anthrax: where margins are merging between emerging threats and bioterrorism","volume":"62","author":"Banerjee","year":"2017","journal-title":"Indian J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2025.01.081_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/jama.287.7.869","article-title":"Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant","volume":"287","author":"Freedman","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jaad.2025.01.081_bib22","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3201\/eid2009.131481","article-title":"Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009\u20132010","volume":"20","author":"Booth","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/microorganisms8010125","article-title":"Detection and identification of Bacillus anthracis: from conventional to molecular microbiology methods","volume":"8","author":"Zasada","year":"2020","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.081_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jac\/dkh258","article-title":"Selection of Bacillus anthracis isolates resistant to antibiotics","volume":"54","author":"Athamna","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jaad.2025.01.081_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7206a1","article-title":"CDC guidelines for the prevention and treatment of anthrax, 2023","volume":"72","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib33","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1371\/journal.pmed.0050003","article-title":"Plague: past, present, and future","volume":"5","author":"Stenseth","year":"2008","journal-title":"PLoS Med"},{"issue":"9568","key":"10.1016\/j.jaad.2025.01.081_bib34","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(07)60566-2","article-title":"Plague","volume":"369","author":"Prentice","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jaad.2025.01.081_bib37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/1469-0691.12706","article-title":"History of biological warfare and bioterrorism","volume":"20","author":"Barras","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.jaad.2025.01.081_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011509","article-title":"A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings","volume":"17","author":"Bourner","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.jaad.2025.01.081_bib41","article-title":"Rapid diagnostic tests for plague","volume":"6","author":"Jullien","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"70 Suppl 1","key":"10.1016\/j.jaad.2025.01.081_bib42","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/cid\/ciz1226","article-title":"Antimicrobial treatment of human plague: a systematic review of the literature on individual cases, 1937-2019","volume":"70","author":"Nelson","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.081_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7003a1","article-title":"Antimicrobial treatment and Prophylaxis of plague: Recommendations for naturally acquired infections and bioterrorism response","volume":"70","author":"Nelson","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"6 Pt A","key":"10.1016\/j.jaad.2025.01.081_bib46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tmaid.2014.10.007","article-title":"An overview: tularemia and travel medicine","volume":"12","author":"Ulu-Kilic","year":"2014","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01652176.2023.2277753","article-title":"Tularemia - a re-emerging disease with growing concern","volume":"43","author":"Sharma","year":"2023","journal-title":"Vet Q"},{"key":"10.1016\/j.jaad.2025.01.081_bib48","series-title":"Defense against biological attacks","first-page":"239","article-title":"Francisella tularensis: causative agent of tularemia and biothreat agent","author":"Barel","year":"2019"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.081_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.idc.2006.03.002","article-title":"Tularemia: current epidemiology and disease management","volume":"20","author":"Eliasson","year":"2006","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"10.1016\/j.jaad.2025.01.081_bib50","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1080\/00365540701402970","article-title":"Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years","volume":"39","author":"Eliasson","year":"2007","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"10.1016\/j.jaad.2025.01.081_bib51","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/cis706","article-title":"Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases","volume":"55","author":"Weber","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.081_bib52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.idc.2008.03.004","article-title":"Tularemia","volume":"22","author":"Nigrovic","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jaad.2025.01.081_bib54","series-title":"Manual of clinical microbiology","first-page":"871","article-title":"Francisella","author":"Dietrich","year":"2019"},{"key":"10.1016\/j.jaad.2025.01.081_bib55","series-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","first-page":"2759","article-title":"Francisella tularensis (tularemia)","volume":"227","author":"Auwaerter","year":"2020"},{"issue":"9","key":"10.1016\/j.jaad.2025.01.081_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy176","article-title":"Tetracyclines for treatment of tularemia: a case series","volume":"5","author":"Rojas-Moreno","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.jaad.2025.01.081_bib57","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1310\/hpj5004-274","article-title":"Ciprofloxacin: tularemia (adults)","volume":"50","author":"Generali","year":"2015","journal-title":"Hosp Pharm"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.081_bib58","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/AAC.50.2.824.2006","article-title":"Tularemia and once-daily gentamicin","volume":"50","author":"Hassoun","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.jaad.2025.01.081_bib59","doi-asserted-by":"crossref","first-page":"O1042","DOI":"10.1111\/1469-0691.12741","article-title":"Evaluation of tularaemia courses: a multicentre study from Turkey","volume":"20","author":"Erdem","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaad.2025.01.081_bib61","series-title":"Smallpox and Its Eradication","first-page":"1371","author":"Fenner","year":"1988"},{"key":"10.1016\/j.jaad.2025.01.081_bib63","series-title":"Bioterrorism and infectious agents: a new dilemma for the 21st century","first-page":"147","article-title":"Smallpox as a weapon for bioterrorism","author":"Lane","year":"2009"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib64","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41392-023-01675-2","article-title":"Mpox (formerly monkeypox): pathogenesis, prevention, and treatment","volume":"8","author":"Lu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.081_bib65","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/v12020138","article-title":"Smallpox in the post-eradication era","volume":"12","author":"Meyer","year":"2020","journal-title":"Viruses"},{"issue":"9508","key":"10.1016\/j.jaad.2025.01.081_bib68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(06)68143-9","article-title":"Smallpox","volume":"367","author":"Moore","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2025.01.081_bib74","article-title":"Viral hemorrhagic fever: molecular pathogenesis and current trends of disease management-an update","volume":"2","author":"Mariappan","year":"2021","journal-title":"Curr Res Virol Sci"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7861\/clinmedicine.15-1-61","article-title":"Viral haemorrhagic fever","volume":"15","author":"Fhogartaigh","year":"2015","journal-title":"Clin Med"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib76","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(18)30298-6","article-title":"Confronting the threat of bioterrorism: realities, challenges, and defensive strategies","volume":"19","author":"Green","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2025.01.081_bib77","first-page":"E1","article-title":"Viral hemorrhagic fevers are often cited by the emerging infections and bioterrorism scientific communities. Introduction","volume":"1171","author":"Rollin","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib78","first-page":"e1","article-title":"An overview of the viral haemorrhagic fevers for the primary care doctor","volume":"62","author":"Govender","year":"2020","journal-title":"S Afr Fam Pract (2004)"},{"key":"10.1016\/j.jaad.2025.01.081_bib80","series-title":"StatPearls [internet]","article-title":"Viral hemorrhagic fevers","author":"Mangat","year":"2024"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib81","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2165079915607496","article-title":"Ebola update","volume":"64","author":"O'Keefe","year":"2016","journal-title":"Workplace Health Saf"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib85","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.081_bib86","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2008.09.007","article-title":"Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea","volume":"81","author":"Rusnak","year":"2009","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.081_bib87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jiph.2022.01.005","article-title":"A systematic review of Ebola virus disease outbreaks and an analysis of the efficacy and safety of newer drugs approved for the treatment of Ebola virus disease by the US Food and Drug Administration from 2016 to 2020","volume":"15","author":"Sivanandy","year":"2022","journal-title":"J Infect Public Health"},{"issue":"8","key":"10.1016\/j.jaad.2025.01.081_bib88","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1358\/dot.2021.57.8.3280599","article-title":"Atoltivimab\/maftivimab\/odesivimab (Inmazeb) combination to treat infection caused by Zaire ebolavirus","volume":"57","author":"Saxena","year":"2021","journal-title":"Drugs Today (Barc)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225001793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225001793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:48:54Z","timestamp":1766112534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225001793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0190962225001793"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.081","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of category A bioweapons with cutaneous features: Epidemiology, clinical presentation, and contemporary management strategies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}